Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

bluebird bio Inc (NASDAQ:BLUE)

44.55
Delayed Data
As of Feb 12
 +1.23 / +2.84%
Today’s Change
37.40
Today|||52-Week Range
197.35
-30.63%
Year-to-Date

Today’s Trading

Previous close43.32
Today’s open43.83
Day’s range42.19 - 45.39
Volume1,577,047
Average volume (3 months)1,640,220
Market cap$1.6B
Dividend yield--
Data as of 4:00pm ET, 02/12/2016

Growth & Valuation

Earnings growth (last year)+9.41%
Earnings growth (this year)-152.03%
Earnings growth (next 5 years)-23.75%
Revenue growth (last year)+25.97%
P/E ratioNM
Price/Sales95.78
Price/Book2.93

Competitors

 Today’s
change
Today’s
% change
OPHTOphthotech Corp+1.50+3.26%
NVAXNovavax Inc+0.08+1.77%
KITEKite Pharma Inc+1.88+4.59%
RDUSRadius Health Inc+0.80+3.06%
Data as of 4:00pm ET, 02/12/2016

Financials

Next reporting dateMarch 2, 2016
EPS forecast (this quarter)-$1.11
Annual revenue (last year)$25.4M
Annual profit (last year)-$48.7M
Net profit margin-191.61%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Nick Leschly
Chief Operating Officer
Jeffrey T. Walsh
Corporate headquarters
Cambridge, Massachusetts

Forecasts

Partner Offers